CMO Turner Durant sells 7,417 shares at $97.25 avg for $721.3K; retains 72.6K shares
Turner Christopher Durant, Chief Medical Officer, executed 7 separate sales totaling 7,417 shares for $721,320.39 over two trading days (January 5-6, 2026) at prices ranging from $96.06 to $98.52 per share. The CMO retained 72.6K shares after the transaction, representing a 9.3% reduction in holdings. Nuvalent reported net income of $-122,437,000.00 over its most recent full fiscal year, and the current stock price of $106.82 stands 2.8% below the 52-week high of $109.86, placing the sale prices materially below the subsequent recovery. The sale occurs in a biotech context where the company remains unprofitable and the stock has risen 21.4% over the prior 90 days.